I just came across a fascinating study from earlier this month that explores innovative delivery systems for CRISPR, specifically using viral vectors to enhance targeting efficiency. The research shows a significant increase in precision, reducing off-target effects — a key concern in gene editing. I wondered if others have experience with these new methods or insights on their practical applications in clinical settings?